Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters.

导出原文传递

翻译打印收藏纠错

作者： Sang-In,Park ^[1] ; Sohyun,Park ^[2] ; Kunse,Lee ^[3] ; Hye Won,Kwak ^[4] ; Yong Kwan,Kim ^[1] ; Hyeong-Jun,Park ^[4] ; Yoo-Jin,Bang ^[5] ; Jae-Yong,Kim ^[5] ; Daegeun,Kim ^[1] ; Ki-Weon,Seo ^[3] ; Su Jeen,Lee ^[3] ; Hun,Kim ^[3] ; Yeonhwa,Kim ^[2] ; Do-Hyung,Kim ^[4] ; Hyo-Jung,Park ^[5] ; Seo-Yeon,Jung ^[3] ; Eulhae,Ga ^[6] ; Jaehyun,Hwang ^[6] ; Woonsung,Na ^[6] ; So-Hee,Hong ^[7] ; Sang-Myeong,Lee ^[8] ; Jae-Hwan,Nam ^[9]

作者单位： SML Biopharm, Gwangmyeong, Republic of Korea. ^[1] Chungbuk National University, Cheongju, Republic of Korea. ^[2] SK Bioscience, Seongnam, Republic of Korea. ^[3] SML Biopharm, Gwangmyeong, Republic of Korea; The Catholic University of Korea, Bucheon, Republic of Korea. ^[4] The Catholic University of Korea, Bucheon, Republic of Korea. ^[5] Chonnam National University, Gwangju, Republic of Korea. ^[6] Ewha Womans University, Seoul, Republic of Korea. ^[7] Chungbuk National University, Cheongju, Republic of Korea. Electronic address: smlee@chungbuk.ac.kr. ^[8] The Catholic University of Korea, Bucheon, Republic of Korea. Electronic address: jhnam@catholic.ac.kr. ^[9]

关键词 Intranasal vaccination Measles virus vector Messenger RNA SARS-CoV-2